Opaleye Management Inc.
Q4 2024 13F Holdings
- Locationboston, MA
- Num holdings
39
- Value ($000)
$571,423
- Date Filed02/14/2025
- Form type13F-HR
- CIK0001595855
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
HROW HARROW HEALTH INC | COM | 415858109 | $133.86M | 23 % | 3,990,000 | ||
TG THERAPEUTICS INC | COM | 88322Q108 | $68.03M | 12 % | 2,260,000 | ||
CDXS CODEXIS INC | COM | 192005106 | $42.17M | 7 % | 8,840,000 | ||
ETON ETON PHARMACEUTICALS INC | COM | 29772L108 | $37.99M | 7 % | 2,852,070 | ||
OCUL OCULAR THERAPEUTIX INC | COM | 67576A100 | $37.08M | 7 % | 4,342,500 | ||
ARVN ARVINAS INC | COM | 04335A105 | $33.64M | 6 % | 1,625,000 | ||
RYTM RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | $27.99M | 5 % | 500,000 | ||
IMNM IMMUNOME INC | COM | 45257U108 | $21.66M | 4 % | 2,040,000 | ||
LQDA LIQUIDIA CORPORATION | COM NEW | 53635D202 | $19.97M | 4 % | 1,698,142 | ||
EWTX EDGEWISE THERAPEUTICS INC | COM | 28036F105 | $12.82M | 2 % | 480,000 |
Rows Per Page
10
- 10
- 50
- 100